EUDA Health Holdings Price to Book Ratio 2022-2023 | EUDA

Historical price to book ratio values for EUDA Health Holdings (EUDA) over the last 10 years. The current price to book ratio for EUDA Health Holdings as of May 10, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

EUDA Health Holdings Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-05-10 2.22 0.00
2023-03-31 1.50 $-0.29 -5.10
2022-03-31 9.84 0.00
2021-12-31 9.75 0.00
2022-12-31 1.65 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.046B $0.010B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.763B 20.73
Inspire Medical Systems (INSP) United States $5.181B 0.00
Axonics (AXNX) United States $3.439B 0.00
10x Genomics (TXG) United States $3.145B 0.00
IRhythm Technologies (IRTC) United States $3.107B 0.00
Azenta (AZTA) United States $2.928B 159.12
Olink Holding AB (publ) (OLK) Sweden $2.910B 0.00
Enovis (ENOV) United States $2.800B 20.75
Hims & Hers Health (HIMS) United States $2.768B 0.00
Privia Health (PRVA) United States $2.139B 120.20
Schrodinger (SDGR) United States $1.673B 0.00
Omnicell (OMCL) United States $1.389B 48.02
Phreesia (PHR) United States $1.238B 0.00
Standard BioTools (LAB) United States $0.699B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Definitive Healthcare (DH) United States $0.610B 0.00
Talkspace (TALK) United States $0.483B 0.00
Clover Health Investments (CLOV) United States $0.428B 0.00
Health Catalyst (HCAT) United States $0.394B 0.00
Pulmonx (LUNG) United States $0.340B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.314B 0.00
P3 Health Partners (PIII) United States $0.231B 0.00
Butterfly Network (BFLY) United States $0.205B 0.00
Outset Medical (OM) United States $0.169B 0.00
American Well (AMWL) United States $0.152B 0.00
TruBridge (TBRG) United States $0.123B 5.26
Augmedix (AUGX) United States $0.122B 0.00
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.073B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.060B 0.00
Zepp Health (ZEPP) China $0.054B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Movano (MOVE) United States $0.039B 0.00
Akili (AKLI) United States $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
CareCloud (CCLD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00